Brown Capital Management LLC Repligen Corp Transaction History

Brown Capital Management LLC

$2.32 Billion
Q3 2025

A detailed history of Brown Capital Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Brown Capital Management LLC holds 668,858 shares of RGEN stock, worth $102 Million. This represents 3.86% of its overall portfolio holdings.

Number of Shares

668,858

Previous 1,005,276 33.47%

Holding current value

$102 Million

Previous $125 Million 28.5%

% of portfolio

3.86%

Previous 3.75%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	SELL	$111.43 - $134.0 $37.5 Million - $45.1 Million	-336,418 Reduced 33.47%	668,858 $89.4 Million
Q2 2025 Aug 13, 2025	BUY	$108.89 - $145.23 $15.4 Million - $20.5 Million	141,241 Added 16.35%	1,005,276 $125 Million
Q1 2025 May 15, 2025	SELL	$127.24 - $174.24 $11.6 Million - $15.8 Million	-90,905 Reduced 9.52%	864,035 $110 Million
Q4 2024 Feb 14, 2025	SELL	$123.41 - $160.92 $20.3 Million - $26.5 Million	-164,639 Reduced 14.71%	954,940 $137 Million
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $20.9 Million - $29.1 Million	-174,099 Reduced 13.46%	1,119,579 $167 Million

Q2 2024 Aug 12, 2024	BUY	$120.0 - $182.95 $16.7 Million - $25.4 Million	139,043 Added 12.04%	1,293,678 $163 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $63.3 Million - $77.2 Million	-370,429 Reduced 24.29%	1,154,635 $212 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $9.52 Million - $15.5 Million	83,416 Added 5.79%	1,525,064 $274 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $494,750 - $629,258	-3,565 Reduced 0.25%	1,441,648 $229 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $670,644 - $873,601	4,845 Added 0.34%	1,445,213 $204 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $1.85 Million - $2.37 Million	-11,967 Reduced 0.82%	1,440,368 $243 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $46.7 Million - $63.5 Million	-287,699 Reduced 16.53%	1,452,335 $246 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.73 Million - $4.36 Million	-17,013 Reduced 0.97%	1,740,034 $326 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $42.5 Million - $56.8 Million	302,286 Added 20.78%	1,757,047 $285 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $71.7 Million - $115 Million	444,646 Added 44.02%	1,454,761 $274 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $1.82 Million - $2.24 Million	-7,362 Reduced 0.72%	1,010,115 $268 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $363,830 - $605,624	1,868 Added 0.18%	1,017,477 $294 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $48.4 Million - $64.5 Million	291,789 Added 40.31%	1,015,609 $203 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $131 Million - $164 Million	723,820 New	723,820 $141 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

58.7M

Call Options Held

321K

Put Options Held

667K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Capital Management LLC with notifications on news.

Account

Brown Capital Management LLC Repligen Corp Transaction History